China NMPA Product Recall - Implantable cardiac resynchronization therapy pacemaker; Implantable cardiac resynchronization therapy pacemaker (Inliven); Implantable cardiac resynchronization therapy pacemaker (trade name: Intua); Implantable Bradycardia Pacemaker; Implantable cardiac pacemaker; Implant; Implantable cardiac pacemaker; Implantable cardiac pacemaker; Implantable cardiac pacemaker; Implantable cardiac pacemaker; Implantable cardiac pacemaker (trade name: Vitalio)

China NMPA product recall for Implantable cardiac resynchronization therapy pacemaker; Implantable cardiac resynchronization therapy pacemaker (Inliven); Implantable cardiac resynchronization therapy pacemaker (trade name: Intua); Implantable Bradycardia Pacemaker; Implantable cardiac pacemaker; Implant; Implantable cardiac pacemaker; Implantable cardiac pacemaker; Implantable cardiac pacemaker; Implantable cardiac pacemaker; Implantable cardiac pacemaker (trade name: Vitalio) by Boston Scientific International Medical Trade (Shanghai) Co., Ltd. published June 07, 2021. Recall level: Level 2 Recall. Boston Scientific International Medical Trading (Shanghai) Co., Ltd. initiated a voluntary Class II